IDEXX Labs Files 2024 Executive Compensation Report

Ticker: IDXX · Form: DEF 14A · Filed: Mar 28, 2025 · CIK: 874716

Idexx Laboratories Inc /De DEF 14A Filing Summary
FieldDetail
CompanyIdexx Laboratories Inc /De (IDXX)
Form TypeDEF 14A
Filed DateMar 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: executive-compensation, proxy-statement, annual-report

Related Tickers: IDXX

TL;DR

IDEXX exec comp filing out - see how they're getting paid for 2024.

AI Summary

IDEXX Laboratories Inc. filed its DEF 14A on March 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards and the fair value of option awards, reflecting the company's compensation structure for its key personnel. This annual report provides transparency into how the company rewards its leadership.

Why It Matters

This filing provides shareholders with crucial information about how IDEXX Laboratories compensates its top executives, impacting corporate governance and investor confidence.

Risk Assessment

Risk Level: low — This is a routine annual filing detailing executive compensation and does not present new or unusual risks.

Key Numbers

  • 2024 — Fiscal Year (Executive compensation details pertain to this year.)
  • 2023 — Prior Fiscal Year (Comparative compensation data may be presented.)

Key Players & Entities

  • IDEXX LABORATORIES INC /DE (company) — Filer
  • 0000874716 (company) — Central Index Key
  • 2024-12-31 (date) — Fiscal Year End
  • 20250328 (date) — Filing Date

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, including the election of directors and executive compensation.

When was this DEF 14A filing submitted by IDEXX Laboratories?

This DEF 14A filing was submitted on March 28, 2025.

What fiscal year does the compensation information in this filing primarily cover?

The compensation information in this filing primarily covers the fiscal year ending December 31, 2024.

What is IDEXX Laboratories' Standard Industrial Classification code?

IDEXX Laboratories' Standard Industrial Classification code is 2835, for 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.

Where is IDEXX Laboratories' principal business address?

IDEXX Laboratories' principal business address is One IDEXX Drive, Westbrook, Maine, 04092-2041.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 28, 2025 regarding IDEXX LABORATORIES INC /DE (IDXX).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.